Clinical lung cancer

01 17 October 2026

DOI 10.1016/j.cllc.2026.10.007

Restoration of Lung Cancer Treatment After Successful Management of Aplastic Anemia: A Report of Two Cases Including a Case of Osimertinib Rechallenge

Open DOI

Yasutaka Watanabe, Gen Kida, Hirofumi Kobayashi et al.

02 14 October 2026

DOI 10.1016/j.cllc.2026.10.006

Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting

Open DOI

Aruna Nambirajan, Kaustar Yadav, Saumya Sahu et al.

03 13 October 2026

DOI 10.1016/j.cllc.2026.10.003

CLINICAL AND RADIOLOGICAL PREDICTORS OF PATHOLOGICAL RESPONSE TO CHEMO-IMMUNOTHERAPY IN SURGICALLY RESECTED NON-SMALL CELL LUNG CANCER

Open DOI

Giorgio Cannone, Luigi Lione, Ester Rosa et al.

04 13 October 2026

DOI 10.1016/j.cllc.2026.10.001

Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-year update

Open DOI

Hisao Imai, Teppei Yamaguchi, Koichi Azuma et al.

05 13 October 2026

DOI 10.1016/j.cllc.2026.10.005

Risk of developing a subsequent primary lung cancer among adult non-lung cancer survivors: implications for lung cancer screening and supportive care

Open DOI

Matthew T. Warkentin, Yibing Ruan, Hannah Harsanyi et al.

06 9 October 2026

DOI 10.1016/j.cllc.2026.10.004

Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)

Open DOI

J. Kuon, M. Blasi, F. Bozorgmehr et al.

07 8 October 2026

DOI 10.1016/j.cllc.2026.09.009

Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Open DOI

Dasantha Jayamanne, Joseph Chan, Riche Mohan et al.

08 7 October 2026

DOI 10.1016/j.cllc.2026.10.002

Stage I Lung Adenocarcinoma in Young Patients (Aged ≤50 Years): Beyond Female Nonsmokers

Open DOI

Hina Bhat, Hely Ollila, Amina Tidjani et al.

09 21 September 2026

DOI 10.1016/j.cllc.2026.09.007

A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)

Open DOI

Kota Kawabata, Ken Masuda, Keita Miura et al.

10 20 September 2026

DOI 10.1016/j.cllc.2026.09.006

Racial Disparities in Thymic Epithelial Tumors: Insights From a Multiracial Urban Cohort

Open DOI

Erica Pietroluongo, Christine M. Bestvina, Anna Di Lello et al.